These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 38195033)
1. Development of direct compression Acetazolamide tablet with improved bioavailability in healthy human volunteers enabled by cocrystallization with p-Aminobenzoic acid. Kumari N; Roy P; Roy S; Wang C; Das S; Pandey N; Mondal SK; Bose A; Sun CC; Ghosh A Int J Pharm; 2024 Mar; 652():123793. PubMed ID: 38195033 [TBL] [Abstract][Full Text] [Related]
2. Tuning Caco-2 permeability by cocrystallization: Insights from molecular dynamics simulation. Pandey N; Kumari N; Roy P; Mondal SK; Thakur A; Sun CC; Ghosh A Int J Pharm; 2024 Jan; 650():123666. PubMed ID: 38065346 [TBL] [Abstract][Full Text] [Related]
3. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid. Li Z; Matzger AJ Mol Pharm; 2016 Mar; 13(3):990-5. PubMed ID: 26837376 [TBL] [Abstract][Full Text] [Related]
4. Ketoconazole- Martin F; Pop M; Kacso I; Grosu IG; Miclăuş M; Vodnar D; Lung I; Filip GA; Olteanu ED; Moldovan R; Nagy A; Filip X; Bâldea I Mol Pharm; 2020 Mar; 17(3):919-932. PubMed ID: 31986050 [TBL] [Abstract][Full Text] [Related]
5. Investigating the Role of the Reduced Solubility of the Pirfenidone-Fumaric Acid Cocrystal in Sustaining the Release Rate from Its Tablet Dosage Form by Conducting Comparative Bioavailability Study in Healthy Human Volunteers. Kumari N; Roy P; Roy S; Parmar PK; Chakraborty S; Das S; Pandey N; Bose A; Bansal AK; Ghosh A Mol Pharm; 2022 May; 19(5):1557-1572. PubMed ID: 35290064 [TBL] [Abstract][Full Text] [Related]
6. Continuous, simultaneous cocrystallization and formulation of Theophylline and 4-Aminobenzoic acid pharmaceutical cocrystals using twin screw melt granulation. Shaikh R; Walker GM; Croker DM Eur J Pharm Sci; 2019 Sep; 137():104981. PubMed ID: 31295548 [TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of sustained release calcium alginate beads and matrix tablets of acetazolamide. Barzegar-Jalali M; Hanaee J; Omidi Y; Ghanbarzadeh S; Ziaee S; Bairami-Atashgah R; Adibkia K Drug Res (Stuttg); 2013 Feb; 63(2):60-4. PubMed ID: 23447074 [TBL] [Abstract][Full Text] [Related]
8. Development of piroxicam mini-tablets enabled by spherical cocrystallization. Chen H; Wang C; Liu S; Sun CC Int J Pharm; 2020 Nov; 590():119953. PubMed ID: 33039491 [TBL] [Abstract][Full Text] [Related]
9. Enhancing the solubility of natural compound xanthotoxin by modulating stability via cocrystallization engineering. Chen JY; Wu H; Guo CY; Zhu B; Ren GB Int J Pharm; 2019 Dec; 572():118776. PubMed ID: 31678374 [TBL] [Abstract][Full Text] [Related]
10. The development of carbamazepine-succinic acid cocrystal tablet formulations with improved in vitro and in vivo performance. Ullah M; Hussain I; Sun CC Drug Dev Ind Pharm; 2016; 42(6):969-76. PubMed ID: 26460090 [TBL] [Abstract][Full Text] [Related]
11. Interrelation of the dissolution behavior and solid-state features of acetazolamide cocrystals. Arenas-García JI; Herrera-Ruiz D; Morales-Rojas H; Höpfl H Eur J Pharm Sci; 2017 Jan; 96():299-308. PubMed ID: 27650458 [TBL] [Abstract][Full Text] [Related]
12. Material-Sparing and Expedited Development of a Tablet Formulation of Carbamazepine Glutaric Acid Cocrystal- a QbD Approach. Yamashita H; Sun CC Pharm Res; 2020 Jul; 37(8):153. PubMed ID: 32705421 [TBL] [Abstract][Full Text] [Related]
13. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611 [TBL] [Abstract][Full Text] [Related]
14. Aggregate Elasticity, Crystal Structure, and Tableting Performance for p-Aminobenzoic Acid and a Series of Its Benzoate Esters. Singaraju AB; Nguyen K; Jain A; Haware RV; Stevens LL Mol Pharm; 2016 Nov; 13(11):3794-3806. PubMed ID: 27723351 [TBL] [Abstract][Full Text] [Related]
15. Identification of a previously unreported co-crystal form of acetazolamide: a combination of multiple experimental and virtual screening methods. Manin AN; Drozd KV; Surov AO; Churakov AV; Volkova TV; Perlovich GL Phys Chem Chem Phys; 2020 Sep; 22(36):20867-20879. PubMed ID: 32914811 [TBL] [Abstract][Full Text] [Related]
16. Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression. Sun WJ; Aburub A; Sun CC J Pharm Sci; 2017 Jul; 106(7):1772-1777. PubMed ID: 28322940 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of performance of co crystals of mefloquine hydrochloride in tablet dosage form. Shete AS; Yadav AV; Murthy MS Drug Dev Ind Pharm; 2013 May; 39(5):716-23. PubMed ID: 22639963 [TBL] [Abstract][Full Text] [Related]
19. The spray drying of acetazolamide as method to modify crystal properties and to improve compression behaviour. Di Martino P; Scoppa M; Joiris E; Palmieri GF; Andres C; Pourcelot Y; Martelli S Int J Pharm; 2001 Feb; 213(1-2):209-21. PubMed ID: 11165109 [TBL] [Abstract][Full Text] [Related]
20. Cocrystals of Hydrochlorothiazide: Solubility and Diffusion/Permeability Enhancements through Drug-Coformer Interactions. Sanphui P; Devi VK; Clara D; Malviya N; Ganguly S; Desiraju GR Mol Pharm; 2015 May; 12(5):1615-22. PubMed ID: 25800383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]